Literature DB >> 28493158

Common Variable Immunodeficiency Caused by FANC Mutations.

Yujin Sekinaka1, Noriko Mitsuiki2, Kohsuke Imai3,4, Miharu Yabe5, Hiromasa Yabe5, Kanako Mitsui-Sekinaka1, Kenichi Honma1, Masatoshi Takagi2, Ayako Arai6, Kenichi Yoshida7,8, Yusuke Okuno8,9, Yuichi Shiraishi10, Kenichi Chiba10, Hiroko Tanaka10, Satoru Miyano10, Hideki Muramatsu9, Seiji Kojima9, Asuka Hira11, Minoru Takata11, Osamu Ohara12, Seishi Ogawa7,8, Tomohiro Morio2, Shigeaki Nonoyama1.   

Abstract

Common variable immunodeficiency (CVID) is the most common adult-onset primary antibody deficiency disease due to various causative genes. Several genes, which are known to be the cause of different diseases, have recently been reported as the cause of CVID in patients by performing whole exome sequencing (WES) analysis. Here, we found FANC gene mutations as a cause of adult-onset CVID in two patients. B cells were absent and CD4+ T cells were skewed toward CD45RO+ memory T cells. T-cell receptor excision circles (TRECs) and signal joint kappa-deleting recombination excision circles (sjKRECs) were undetectable in both patients. Both patients had no anemia, neutropenia, or thrombocytopenia. Using WES, we identified compound heterozygous mutations of FANCE in one patient and homozygous mutation of FANCA in another patient. The impaired function of FANC protein complex was confirmed by a monoubiquitination assay and by chromosome fragility test. We then performed several immunological evaluations including quantitative lymphocyte analysis and TRECs/sjKRECs analysis for 32 individuals with Fanconi anemia (FA). In total, 22 FA patients (68.8%) were found to have immunological abnormalities, suggesting that such immunological findings may be common in FA patients. These data indicate that FANC mutations are involved in impaired lymphogenesis probably by the accumulation of DNA replication stress, leading to CVID. It is important to diagnose FA because it drastically changes clinical management. We propose that FANC mutations can cause isolated immunodeficiency in addition to bone marrow failure and malignancy.

Entities:  

Keywords:  Common variable immunodeficiency; Fanconi anemia; T-cell receptor excision circles (TRECs); lymphopoiesis; primary immunodeficiencies; signal joint kappa-deleting recombination excision circles (sjKRECs)

Mesh:

Substances:

Year:  2017        PMID: 28493158     DOI: 10.1007/s10875-017-0396-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

Review 1.  Primary immunodeficiency syndromes associated with defective DNA double-strand break repair.

Authors:  A R Gennery
Journal:  Br Med Bull       Date:  2006-09-13       Impact factor: 4.291

2.  Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.

Authors:  Ayako Arai; Ken-Ichi Imadome; Yuko Watanabe; Mayumi Yoshimori; Takatoshi Koyama; Takeharu Kawaguchi; Chiaki Nakaseko; Shigeyoshi Fujiwara; Osamu Miura
Journal:  Int J Hematol       Date:  2011-04-14       Impact factor: 2.490

Review 3.  Immune defects in Fanconi anemia.

Authors:  Sara R Fagerlie; Grover C Bagby
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

4.  Immune defects in a mouse model of Fanconi anaemia.

Authors:  Sigrid C Holmgren; Emily M Goren; Brent L Wood; Pamela S Becker; Jason A Taylor
Journal:  Br J Haematol       Date:  2012-08-16       Impact factor: 6.998

Review 5.  What is the DNA repair defect underlying Fanconi anemia?

Authors:  Julien P Duxin; Johannes C Walter
Journal:  Curr Opin Cell Biol       Date:  2015-11-11       Impact factor: 8.382

6.  Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.

Authors:  K Kawa; A Sawada; M Sato; T Okamura; N Sakata; O Kondo; T Kimoto; K Yamada; S Tokimasa; M Yasui; M Inoue
Journal:  Bone Marrow Transplant       Date:  2010-05-24       Impact factor: 5.483

7.  In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.

Authors:  Miharu Yabe; Hiromasa Yabe; Satoshi Hamanoue; Hiroyasu Inoue; Masae Matsumoto; Takashi Koike; Hiroyuki Ishiguro; Tsuyoshi Morimoto; Satoshi Arakawa; Toshio Ohshima; Atsuko Masukawa; Hayato Miyachi; Takayuki Yamashita; Shunichi Katob
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

Review 8.  Molecular pathogenesis of Fanconi anemia: recent progress.

Authors:  Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

Review 9.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

Review 10.  Interplay between Fanconi anemia and homologous recombination pathways in genome integrity.

Authors:  Johanna Michl; Jutta Zimmer; Madalena Tarsounas
Journal:  EMBO J       Date:  2016-04-01       Impact factor: 11.598

View more
  9 in total

1.  Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors.

Authors:  Dan Zhao; Isa Mambetsariev; Haiqing Li; Chen Chen; Jeremy Fricke; Patricia Fann; Prakash Kulkarni; Yan Xing; Peter P Lee; Andrea Bild; Erminia Massarelli; Marianna Koczywas; Karen Reckamp; Ravi Salgia
Journal:  Lung Cancer       Date:  2020-05-24       Impact factor: 5.705

Review 2.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

3.  Lymphopenia With Clinical and Laboratory Features of Combined Immune Deficiency in an 11-Year-Old Female With FANCD2 Variants and Fanconi Anemia.

Authors:  Roman Deniskin; Ghadir S Sasa; Sarada L Nandiwada; Nicholas L Rider
Journal:  Front Pediatr       Date:  2019-01-18       Impact factor: 3.418

4.  Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients.

Authors:  Minako Mori; Asuka Hira; Kenichi Yoshida; Hideki Muramatsu; Yusuke Okuno; Yuichi Shiraishi; Michiko Anmae; Jun Yasuda; Shu Tadaka; Kengo Kinoshita; Tomoo Osumi; Yasushi Noguchi; Souichi Adachi; Ryoji Kobayashi; Hiroshi Kawabata; Kohsuke Imai; Tomohiro Morio; Kazuo Tamura; Akifumi Takaori-Kondo; Masayuki Yamamoto; Satoru Miyano; Seiji Kojima; Etsuro Ito; Seishi Ogawa; Keitaro Matsuo; Hiromasa Yabe; Miharu Yabe; Minoru Takata
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

5.  Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer.

Authors:  Bo Lin; Hao Li; Tianwen Zhang; Xin Ye; Hongyu Yang; Yuehong Shen
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

Review 6.  The Primary Immunodeficiency Database in Japan.

Authors:  Kanako Mitsui-Sekinaka; Yujin Sekinaka; Akifumi Endo; Kohsuke Imai; Shigeaki Nonoyama
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

7.  Common variable immunodeficiency: different faces of the same disease.

Authors:  Elżbieta Grześk; Anna Dąbrowska; Anna Urbañczyk; Marlena Ewertowska; Mariusz Wysocki; Sylwia Kołtan
Journal:  Postepy Dermatol Alergol       Date:  2021-11-05       Impact factor: 1.837

Review 8.  Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.

Authors:  Serine Avagyan; Akiko Shimamura
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

9.  Case Report: Metagenomic Next-Generation Sequencing Can Contribute to the Diagnosis and Treatment of Disseminated Visceral Kaposi Sarcoma Following Allogeneic Haematopoietic Stem Cell Transplantation.

Authors:  Kuangguo Zhou; Jinhuan Xu; Zhen Shang; Hanying Sun; Kefeng Shen; Yi Xiao
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.